The Biotechnology (BIOTEC) section is comprised of members from diverse backgrounds in industry, academia, and government who share a common interest in the evolving field of biotechnology. The successful discovery, manufacture, delivery, and authorization for marketing of biotechnology derived pharmaceuticals requires collaboration between many diverse areas including but not limited to molecular biology, cell culture, analytical biochemistry, formulation, bioanalysis, pharmacokinetics, metabolism, toxicology, clinical, and regulatory affairs. Thus the primary goal of this section is to unite multiple scientific disciplines in a forum where experimental results and experiences are shared and evolving concerns on the research, development, and manufacture of biotechnology based pharmaceuticals are discussed. BIOTEC section members meet at national, regional, and web-based meetings or teleconferences to present scientific data, exchange ideas on emerging trends and new technologies, and contribute to regulatory guidelines. This section is of interest to basic, applied, and clinical scientists.
Find us on